<DOC>
	<DOCNO>NCT00692562</DOCNO>
	<brief_summary>The aim study evaluate efficiency safety simultaneous islet-kidney transplantation patient type 1 diabetes end-stage renal disease use glucocorticoid-free immunosuppressive regimen alemtuzumab induction . Islet transplantation result insulin independence excellent metabolic control glucocorticoid-free immunosuppression combine infusion adequate islet mass . Alemtuzumab ( Campath-1H ® ) 150-kDa humanized IgG1 monoclonal antibody target CD52 antigen . Prolonged lymphocyte depletion expect follow alemtuzumab treatment .</brief_summary>
	<brief_title>Simultaneous Islet-Kidney Transplantation Patients Type 1 Diabetes With End-stage Renal Disease</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<criteria>Male female patient age 18 60 year age . Ability provide write informed consent . Clinical history compatible type 1 diabetes ( T1DM ) define WHO guideline ( 1999 ) Diagnosis classification Diabetes Mellitus . manifest sign symptom severe enough incapacitating . Basal Cpeptide &lt; 0.5ng/mL patient poor diabetes control ( HbA1c &gt; 7 % &lt; 12 % ) progressive diabetic complication . endstage renal disease ( serum creatinine &gt; 450μmol/l ) age &lt; 18 year &gt; 60 year diabetic history &lt; 5 year BMI &gt; 27 body weight &gt; 80kg exogenous insulin requirement &gt; 1 unit/kg/day severe anemia ( male &lt; 8g/dl , female &lt; 7g/dl ) low white blood cell count ( &lt; 3000/dl ) liver dysfunction Symptomatic peptic ulcer disease Any malignancy Active infection include hepatitis B , hepatitis C , HIV , TB panel reactive antibody &gt; 20 % Any medical condition , opinion investigator , interfere safe completion trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>Islets Langerhans Transplantation</keyword>
	<keyword>Kidney Transplantation</keyword>
	<keyword>Type 1 Diabetes Mellitus</keyword>
	<keyword>alemtuzumab</keyword>
</DOC>